AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott ... AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott Laboratories in 2013, AbbVie focuses primarily on advanced therapies in immunology, oncology, neuroscience, and virology. Its product portfolio includes notable drugs such as Humira for autoimmune diseases, Skyrizi and Rinvoq for psoriasis and arthritis, as well as oncology treatments like Imbruvica and Venclexta. The company has expanded its pipeline and therapeutic reach through strategic acquisitions, including Allergan, which added aesthetic products like Botox, and more recent acquisitions in neuroscience and oncology. AbbVie plays a significant role in the healthcare sector by providing treatments addressing complex and chronic conditions, with a strong emphasis on innovation and broad market impact.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for AbbVie

We have not yet reviewed AbbVie's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review AbbVie's data?

Create a free Tracenable account to signal interest in having our team review data for AbbVie.

Legal Center Contact Us